2022
DOI: 10.3390/children9101541
|View full text |Cite
|
Sign up to set email alerts
|

Neonatal Hyperglycemia and Neurodevelopmental Outcomes in Preterm Infants: A Review

Abstract: Glucose impairment is common in preterm infants but the impact of early neonatal hyperglycemia on long term neurodevelopment is still highly controversial. This review reports current evidence of the effect of hyperglycemia on neurodevelopmental outcome. It was conducted according to the PRISMA guidelines. We searched MEDLINE via PubMed; EMBASE via Ovid; the Cochrane Central Register of Controlled Trials; the Cochrane Library; ClinicalTrials.gov; and the World Health Organization’s International Trials Registr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 39 publications
(102 reference statements)
0
1
0
Order By: Relevance
“…High levels of blood glucose are most commonly reported within the first 3 to 5 days of life, as a consequence of limited insulin secretion capacity, increased counterregulatory hormones, sepsis, parenteral glucose and medications' administration (e.g. steroids) (99). Moreover, due to environmental (drugs, parental glucose infusion, sepsis, intrauterine growth restriction) and intrinsic factors (e.g.…”
Section: Neonatal Hyperglycemiamentioning
confidence: 99%
“…High levels of blood glucose are most commonly reported within the first 3 to 5 days of life, as a consequence of limited insulin secretion capacity, increased counterregulatory hormones, sepsis, parenteral glucose and medications' administration (e.g. steroids) (99). Moreover, due to environmental (drugs, parental glucose infusion, sepsis, intrauterine growth restriction) and intrinsic factors (e.g.…”
Section: Neonatal Hyperglycemiamentioning
confidence: 99%